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Abstract
Background: Rabies is an incurable neglected zoonosis with worldwide distribution characterized as a lethal
progressive acute encephalitis caused by a lyssavirus. Animal venoms and secretions have long been studied as new
bioactive molecular sources, presenting a wide spectrum of biological effects, including new antiviral agents. Bufotenine,
for instance, is an alkaloid isolated from the skin secretion of the anuran Rhinella jimi that inhibits cellular penetration by
the rabies virus. Antimicrobial peptides, such as ocellatin-P1 and ocellatin-F1, are present in the skin secretion of anurans
from the genus Leptodactylus and provide chemical defense against predators and microorganisms.
Methods: Skin secretion from captive Leptodactylus labyrinthicus was collected by mechanical stimulation, analyzed by
liquid chromatography and mass spectrometry, and assayed for antiviral and cytotoxic activities. Synthetic peptides were
obtained using solid phase peptide synthesis, purified by liquid chromatography and structurally characterized by mass
spectrometry, and assayed in the same models. Cytotoxicity assays based on changes in cellular morphology were
performed using baby hamster kidney (BHK-21) cells. Fixed Rabies virus (Pasteur Virus – PV) strain was used for virological
assays based on rapid fluorescent focus inhibition test.
Results: Herein, we describe a synergic effect between ocellatin-F1 and bufotenine. This synergism was observed when
screening the L. labyrinthicus skin secretion for antiviral activities. The active fraction major component was the
antimicrobial peptide ocellatin-F1. Nevertheless, when the pure synthetic peptide was assayed, little antiviral activity
was detectable. In-depth analyses of the active fraction revealed the presence of residual alkaloids together with
ocellatin-F1. By adding sub-effective doses (e.g. < IC50) of pure bufotenine to synthetic ocellatin-F1, the antiviral effect
was regained. Moreover, a tetrapetide derived from ocellatin-F1, based on alignment with the virus’s glycoprotein region
inferred as a possible cell ligand, was able to maintain the synergic antiviral activity displayed by the full peptide.
Conclusions: This novel antiviral synergic effect between a peptide and an alkaloid may present an innovative lead for
the study of new antiviral drugs.
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Background
Rabies is an incurable zoonosis with worldwide distribu-
tion characterized as a lethal progressive acute encephal-
itis responsible for more than 55 thousand deaths per
year, mostly in Asia and Africa [1]. In Brazil, according
to the Ministry of Health, there have been 780 notified
human rabies cases from 1986 to 2015 [2]. It is caused by
a neurotropic enveloped virus, the Rabies virus, which has
a single non-segmented negative strand RNA genome that
encodes five proteins: nucleoprotein, RNA-dependent
RNA polymerase, phosphoprotein, matrix protein and
glycoprotein [3].
Glycoprotein is a membrane protein that forms trimers
on the viral surface and it is the major antigen responsible
for inducing the production of virus-neutralizing and pro-
tective antibodies [4]. It is also the protein that most
contributes to the viral pathogenicity, by binding to specific
host cell receptors, promoting the virus’s entry into the
cells [5]. The first described target for glycoprotein binding
was a nicotinic acetylcholine receptor (nAChR) [6]. Other
molecules, such as the neural cell adhesion molecule
(NCAM) and the low-affinity neurotrophin receptor
(p75NTR), are also considered mediators of the virus’s en-
trance into the host cells [7, 8].
Different organisms have been used as sources of bio-
logically active molecules [9]. Amphibian skin extract and
secretions contain a great diversity of bioactive com-
pounds that provide chemical protection against predators
and microorganisms [10]. Several bioactive molecules,
such as alkaloids, steroids and peptides, have been iso-
lated from the anurans skin secretion [11–13]. The
genus Leptodactylus, which includes 75 species spread
across southern North America, South America and
the West Indies, has already been prospected for such
bioactive molecules, including by our group [14, 15].
The alkaloid leptodactyline, for example, possesses
muscle relaxant action and neuromuscular blocking
effects [16]. Ocellatin-P1 (formerly known as pentadac-
tylin, according to the nomenclature proposed by Con-
lon [17]), an antimicrobial peptide isolated from the skin
secretion of Leptodactylus pentadactylus, is active against
several gram-negative and gram-positive bacteria; whereas
ocellatin-F1 (previously known as fallaxin), obtained from
the giant ditch frog Leptodactylus fallax skin secretion,
presents antimicrobial activity against gram-negative bac-
teria [17–19].
Taking into account that the amphibian skin secretions
are rich sources of bioactive molecules – including anti-
viral molecules – and that the biochemical characterization
of molecules isolated from Leptodactylus labyrinthicus is
still incipient, the aim of this study was to screen the skin
secretion of L. labyrinthicus to search for bioactive mole-




All reagents employed in this work were of analytical
grade and were purchased from Sigma Aldrich Co.
(USA), unless otherwise stated. Bufotenine was purified
from Anadenanthera colubrina seeds, as previously de-
scribed [11].
Collection of specimens and extraction of skin secretions
The collection and housing of L. labyrinthicus were per-
formed under license number 15964–1 from the Brazil-
ian Institute of Environment and Renewable Natural
Resources (IBAMA). Three adult male specimens were
collected in Araraquara (SP, Brazil) and maintained in
captivity at the Laboratory of Cell Biology, Butantan In-
stitute (SP, Brazil). The skin secretions were mechanic-
ally collected by submerging and gently compressing the
specimens in deionized water. The aqueous solutions
obtained were lyophilized and stored at −20 °C.
Samples preparation
Skin secretions were filtered in 10 kDa cut-off mem-
branes (Amicon Ultra-4, Millipore). Filtered contents
were used in the subsequent steps.
Reversed-phase liquid chromatography
Skin secretion solutions were analyzed by reversed-
phase high-performance liquid chromatography (RP-
HPLC) using a binary HPLC system (20A Prominence,
Shimadzu Co., Japan). Aliquots of the secretions were
loaded in a C18 monolithic column (Phenomenex, 100
mm × 4.6 mm), in a two solvent system: (A1) trifluoroa-
cetic acid (TFA)/water (1:1,000) and (B1) TFA/aceto-
nitrile (ACN)/water (1:900:100). The column was eluted
at a constant flow rate of 2 mL.min−1 with a 0 to 100 %
gradient of solvent B1 over 13 min. The eluates were
monitored by a Shimadzu SPD-M20A detector at 214
nm. After skin secretion profiles, fractions were manu-
ally collected and dried for subsequent assays.
Mass spectrometry
Liquid chromatography-mass spectrometry (LC-MS)
LC-MS analyses were performed using an electrospray-
ion trap-time of flight (ESI-IT-TOF) (Shymadzu Co.,
Japan) mass spectrometer equipped with binary ultra-fast
liquid chromatography system (UFLC) (20A Prominence,
Shimadzu Co., Japan). Aliquots of each material were
dried, resuspended in 0.1 % formic acid (FA) and loaded
in a C18 column (Shimadzu-pack XR-ODS, 2.2 μm; 100
mm × 3 mm) in a binary solvent system: (A2) FA/water
(1:1,000) and (B2) FA/ACN/water (1:900:100). The column
was eluted at a constant flow rate of 0.2 mL.min−1 with a
0 to 100 % gradient of solvent B2 over 20 min. The eluates
were monitored by a Shimadzu SPD-M20A PDA detector
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before introduction into the mass spectrometer, in which
the spray voltage was kept at 4.5 kV, the capillary voltage at
1.76 kV, and temperature at 200 °C. MS spectra were ac-
quired under positive ionization mode and collected in the
80–2,000 m/z range. Instrument control, data acquisition,
and data processing were performed with LabSolutions
(LCMS solution 3.60.361 version, Shimadzu Co., Japan).
Direct infusion mass spectrometry
MS analyses were performed in an ESI-IT-TOF as de-
scribed above. Previously dried skin secretion fractions
were resuspended in 0.5 % FA, for positive mode elec-
trospray ionization (ESI+), and manually injected in a
Rheodyne injector at a flow rate of 50 μL.min−1, in 50 %
FA/ACN/water (5:900:100). Instrument control, data ac-
quisition, and data processing were performed by the
software LabSolutions (LCMS solution 3.60.361 version,
Shimadzu Co., Japan).
Peptide synthesis
Synthetic peptides were obtained in an automated bench-
top simultaneous multiple solid-phase synthesizer (PSSM
8 system from Shimadzu Co., Japan) using solid-phase
peptide synthesis by the Fmoc-Procedure [20, 21]. Pep-
tides were purified by reversed-phase chromatography
(Shimadzu Co., Shim-pack Prep-ODS, 5 μm, 20 × 250
mm) semi-preparative HPLC, whereas the purity and
identity of the peptides were confirmed by ESI-IT-TOF
mass spectrometry and by analytical HPLC, under the
same conditions described above.
Cell culture and viruses
Baby hamster kidney (BHK-21, ATCC CCL-10) cells,
grown in Eagle’s minimum essential medium (MEM),
containing Earle’s salts supplemented with 10 % fetal bo-
vine serum (FBS), were used for the cytotoxicity and
virology assays. The fixed Rabies virus (PV) strain was
used for the virology assay [22]. The assays were per-
formed in 96-well microplates.
Cytotoxicity assay
The cytotoxic effect of different molecules was evaluated
by a test based on morphological changes of BHK-21 cells.
Briefly, samples were diluted in MEM-FBS and depos-
ited in 96-well microplates, according to the items de-
scribed below. Using MEM-FBS as diluent, serial fourfold
dilutions of these samples were performed in 50 μL vol-
umes. Then, 100 μL of BHK-21 cells suspension (2.5 ×
105 cells.mL−1) were added to each well and incubated
at 37 °C for 20 h, in a 5 % CO2 atmosphere. Following
incubation, cells were observed in an optical micro-
scope (Carl-Zeiss), using 100× magnification; formation
of a confluent cell monolayer was analyzed in compari-
son to positive [dimethyl sulfoxide – DMSO diluted
into MEM-FBS (1:5)] and negative (MEM-FBS) cyto-
toxicity controls.
Virology assay
The effect of different molecules, dissolved into MEM-
FBS, as interfering agents of rabies virus infection in
BHK-21 cells, was evaluated by rapid fluorescent focus
inhibition test (RFFIT) adapted for microplates [23, 24].
Samples were added to 96-well microplates, according
to the description below.
Using MEM-FBS as diluent, serial fourfold dilutions of
these samples were performed in 50 μL volumes. PV
strain suspension previously titered (30 FFD50), 50 μL,
was added to each well. Then, 100 μL of BHK-21 cellular
suspension (2.5 × 105 cells.mL−1) was added per well
and microplates were incubated at 37 °C, for 20 h, in a 5
% CO2 atmosphere. After incubation, the medium was
aspirated and microplates were cooled on ice. Cell
monolayer was fixed by adding cold 80 % acetone into
the wells. After 15 min, acetone was discarded by inver-
sion and microplates were dried at 37 °C. The staining
step was performed by adding 40 μL of antirabies im-
munoglobulin conjugated with fluorescein isothiocyan-
ate produced by Instituto Pasteur (SP, Brazil) [25],
previously titrated. Microplates were incubated at 37 °
C, for 1 h, in a 5 % CO2 atmosphere. After this, micro-
plates were washed by submerging them in three
changes of phosphate buffered saline (PBS) and then in
three changes of distilled water. Microplates were inverted
and shaken for water removal. Finally, 50 μL of glycerin/
PBS solution (1:10) was added to each well. BHK-21 cells
+ MEM-FBS and PV + BHK-21 cells + MEM-FBS were
used, respectively, as cell viability and virus infectivity con-
trols. Cells were observed in an inverted fluorescence
microscope (Leica DMIL), using 200× magnification, and
18 fields per well were analyzed, and fields containing
fluorescent foci (infected cells) were counted.
Statistical analyses
Samples were assayed in duplicates in both assays. Results
are presented as mean ± standard error of mean. Statis-
tical evaluation of data was carried out by one-way ana-
lysis of variance (ANOVA) followed by Tukey post-test
(virology assay). Differences were considered statistically
significant when p < 0.05.
Results
Initial RP-HPLC analyses of the crude L. labyrinthicus
skin secretions (Fig. 1, inset) suggested similar profiles
among the three specimens, allowing the pooling of the
individual secretions for subsequent fractionation (Fig. 1).
Fractions were manually collected, lyophilized and tested
for cytotoxic and antiviral activity (data not shown).
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Under our experimental conditions only one fraction
(F11) was active and is indicated by the arrow, in Fig. 1.
Mass spectrometric analyses of F11 (Additional file 1)
showed the presence of two peptides: (2547.98 ± 0.16 Da
and 2192.80 ± 0.16 Da), as well as other minor low-
molecular-mass compounds. Both peptides were selected
for MS2 CID fragmentation (Additional file 2, MS2 of
m/z = 850.16) and were de novo sequenced with the aid
of the software Peaks Studio v7 (Bionformatics Solu-
tions Inc., Canada), being identified as ocellatin-F1
(GVVDILKGAAKDIAGHLASKVMNKL; Fig. 2a) and
Des-Lys24-Leu25-ocellatin-F1 (GVVDILKGAAKDIAGH-
LASKVMN; Fig. 2b). Ocellatin-F1, termed OF1, was then
synthesized by the Fmoc procedure and the MS2 CID
spectrum of the triply charged peptide is presented in
Additional file 2, for the sake of comparison with the
natural peptide fragmentation pattern of the corre-
sponding ion.
The peptide sequence of OF1 was then compared with
the rabies virus glycoprotein region that was supposed
to mediate virus internalization (Table 1) and similarity
could be observed (boxed region) between the tetrapeptide
associated with the nAChR recognition, N194-S-R-G197,
and A18-S-K-V21 OF1 internal peptide. Both tetrapeptides
were synthesized by the Fmoc strategy and assayed
for antiviral activity under the same experimental
conditions employed for the screening of the antiviral
activity (Additional file 3). OF1 tetrapeptide was termed
OF1TP and the rabies virus glycoprotein G tetrapeptide
was termed RVGTP. At the tested concentrations, F11,
synthetic OF1, OF1TP and RVGTP did not present cyto-
toxic activity (Additional file 4).
Figure 3 displays the direct immunofluorescence assays
(DIF) used for the determination of the antiviral activity,
assessed by means of identification and counting of viral
particles inside the cells, revealed by the conjugated fluor-
escent antibody. These data were then converted into per-
centage of viral infection inhibition and are presented in
Fig. 4. The F11 (1.0 mg.mL−1) was able to reduce by 6 %
the viral infection (Figs. 3a and 4). However, when syn-
thetic 1.0 mg.mL−1 OF1 was assayed under the same con-
ditions, it caused a diminished inhibitory effect: 3 %
inhibition of infection (Figs. 3b and 4). OF1TP was able to
inhibit 6 % of the viral infection, but only when assayed at
6.0 mg.mL−1 (Figs. 3c and 4). On the other hand, RVGTP
did not inhibit the viral infection (data not shown).
Fig. 1 Representative RP-HPLC profile of the pooled filtered skin secretion of L. labyrinthicus. RP-HPLC profile of L. labyrinthicus skin secretion in a
C18 monolithic column monitored at 214 nm. Numbers 1–16 represent the sixteen fractions manually collected for the antiviral screening; the
arrow indicates the active fraction. Inset: superimposed individual chromatographic profiles of the filtered skin secretions from three individuals,
under the same chromatographic conditions
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In order to understand the reduced effect of OF1 in
relation to F11, its mass spectrum (Additional file 1) was
re-analyzed, thereby revealing the presence of low-
molecular-mass compounds, particularly m/z = 219.13,
identified as N’,N’,N’-trimethyl-5-hydroxytryptamine (5-
HTQ), based on the high accuracy of mass determination,
which allowed formula prediction, and the presence of the
characteristic spontaneous fragment m/z = 160.06. 5-HTQ
is an alkaloid commonly found in amphibian skin secre-
tions, often together with the antiviral alkaloid bufotenine.
In order to investigate the possible synergic effect between
alkaloids and OF1 on the inhibition of the RABV infection,
sub-effective doses of pure plant-derived bufotenine were
assayed under the same conditions (Fig. 3d) and in
association with F11 (Fig. 3e), synthetic OF1 (Fig. 3f),
OF1TP (Fig. 3g) and RVGTP (data not shown).
The 0.8 mg.mL−1 bufotenine dose (corresponding to half
of the IC50 dose for the antiviral effect) was considered sub-
effective, e.g., only capable of inducing mild effects and not
100 % inhibition [11]. This dose was able to cause a 22 % re-
duction in the viral infection (Fig. 4) and was not cytotoxic
for BHK-21 cells (Additional file 4). On the other hand,
when 0.8 mg.mL−1 bufotenine was added to 1 mg.mL−1 F11,
1 mg.mL−1 synthetic OF1 or 6 mg.mL−1 OF1TP, 100 % virus
infection inhibition could be observed, indicating a synergic
effect between the peptide and the alkaloid (Fig. 4), which is
statistically different (p < 0.001) from the infection inhibitory
effect of the molecules tested individually.
Table 1 Sequence alignment between ocellatin-F1 and the RABV glicoprotein G region associated with cell penetration
Only the boxed tetrapeptides were aligned; the gray region was not considered for the alignment. aUniprot: Q85422
Fig. 2 Representative deconvoluted annotated de novo MS2 spectra of ocellatin-F1 and Des-Lys24-Leu25-ocelatin-F1. a ocellatin-F1 and b Des-
Lys24-Leu25-ocelatin-F1, as analyzed by Peaks Studio v7
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Discussion
In this work, we report not only the isolation and bio-
chemical characterization of ocellatin-F1 (OF1) and Des-
Lys24-Leu25-OF1 from the skin secretion of L. labyr-
inthicus, but also that OF1 possesses mild antiviral effect
on the inhibition of rabies virus infection in BHK-21
cells. This effect can reach 100 % when in synergism
with bufotenine, an already know antiviral alkaloid iso-
lated from the skin secretion of Rhinella jimi [11].
In this study, OF1 was isolated through a biological
driven-assay, monitoring anti-rabies activity. The active
fraction – which contained OF1, Des-Lys24-Leu25-OF1
and low-molecular-mass molecules – was able to decrease
the PV rabies virus strain infection in BHK-21 cells.
OF1 was first isolated from the skin secretion of L. fal-
lax, but has also been found in other species from the
genus Leptodactylus, including L. pentadactylus and L.
labyrinthicus [18, 19, 26]. It is a 25-amino-acid residue
peptide able to inhibit the growth of gram-negative bac-
teria (Escherichia coli, Pseudomonas aeruginosa, Entero-
bacter cloacae, Klebsiella pneumoniae), but inactive
against Staphylococcus aureus (gram-positive bacterium)
and the yeast Candida albicans [19]. Rollins-Smith et al.
[19] also mention the structural similarity between OF1
and ranatuerin-2, an antimicrobial peptide from Rana
catesbeiana, which presents antimicrobial activity to-
wards S. aureus [27]. Remarkably, antiviral activity of
ranatuerin-2 has already been reported against the frog
virus 3 (FV3) – capable of causing Amphibia mass mor-
tality – and the channel catfish virus (CCV) – which
causes significant economic loss in channel catfish farms
[28]. Based on these findings, OF1 was elected as the
candidate for the following antiviral tests, performed
with the synthetic molecule. Nevertheless, pure synthetic
OF1 was not as effective as F11 (Fig. 4).
Two possibilities may account for the reduced activity of
OF1: ranatuerin has a disulfide bond at the C-terminus (be-
tween Cys23 and Cys28), whereas OF1 is a linear peptide;
and the identity between OF1 and ranatuerin encompasses
the central part of the peptide (6LKGAAKDI13AGH16L17),
with Ile13 and His16 being not identical but conserved.
Moreover, this identity ceases before the ring region in
ranatuerin and at the residue (Leu17) immediately prior to
the tetrapeptide considered similar to the rabies virus glyco-
protein region associated with the viral cell penetration
(Table 1). Therefore, the determinants of specificity for the
antiviral activity appear to be located at the C-terminal of
these peptides and are distinct.
To test this hypothesis, a fragment of the C-terminal
region of OF1 (considered similar to the rabies virus
glycoprotein) was synthesized and assessed for antiviral
activity. Although the dose was higher (6 mg.mL−1 versus 1
mg.mL−1 for OF1), OF1TP was able to retain its antiviral
activity, corroborating the hypothesis that the antiviral ac-
tivity of these antimicrobial peptides is located at their C-
termini.
Fig. 3 Direct immunofluorescence (DIF) of BHK-21 cell monolayer after treatment with RABV and different molecules. a F11 (1.0 mg.mL−1); b synthetic
OF1 (1.0 mg.mL−1); c OF1TP (6.0 mg.mL−1); d bufotenine (0.8 mg.mL−1); e bufotenine (0.8 mg.mL−1) and F11 (1.0 mg.mL−1); f bufotenine (0.8 mg.mL−1)
and synthetic OF1 (1.0 mg.mL−1); g bufotenine (0.8 mg.mL−1) and OF1TP (6.0 mg.mL−1); h negative control (MEM-FBS only) and i positive control (PV
only). Magnification 200×
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In-depth analyses of the mass spectra of the active fraction
from L. labyrinthicus skin secretion (F11, Additional file 1)
showed that, besides Des-Lys24-Leu25-OF1 that also con-
tains the OF1TP sequence, low-molecular-mass molecules,
particularly 5-HTQ, were also present. Our group has re-
cently described the antiviral effect of bufotenine, structur-
ally a closely related 5-HTQ alkaloid. Bufotenine is an
alkaloid with noxious properties which works as a defense
mechanism against predators and is able to inhibit 100 % of
rabies infection in BHK-21 cells, at 3.9 mg.mL−1 [10, 11, 29].
Based on these pieces of information, a possible syner-
gic effect between bufotenine and OF1 was assayed
(Fig. 3e, f and g and Fig. 4). The level 0.8 mg.mL−1, cor-
responding to half of the IC50, was chosen, for according
to Vigerelli et al. [11] this dose would cause virus inhib-
ition of about 20 % and neglected cytotoxic effects.
Antiviral synergic effects have already been attributed to
amphibian antimicrobial peptides: Chinchar et al. [30]
describe a combined effect between magainin II and
ranatuerin-2P. However, these authors are unsure whether
this would be a synergic effect or a simple additive effect,
for they were able to obtain the same level of innactivation
by simply doubling the peptide dose. Rollings-Smith et al.
[31], on the other hand, were able to describe a true syner-
gic effect between magainin II and PGLa, which present
individual MICs of about 100 μM for Batrachochytrium
dendrobatidis; but, when added together (1:1) to this fun-
gus, their combined MIC drops to 12.5 μM (e.g., 6.25 μM
each). Those authors use the argument that antimicrobial
peptides are naturally produced and secreted into the skin
as a mixture; therefore, synergism should occur. Based on
this same principle, the synergism between OF1 and bufo-
tenine could also be expected and, from the amphibian
perspective, desirable.
Conclusions
Our study shows the synergic effect of OF1 and bufote-
nine against the PV strain of the rabies virus. This is, to
the best of these authors’ knowledge, the first description
of a synergic antiviral effect between a peptide and an al-
kaloid. Moreover, the peptide and the alkaloid are not act-
ing on the virus; rather, their effect (individual or synergic)
is on the viral penetration into the cell. Further investiga-
tions are being conducted in order to evaluate the action
mechanism of the antiviral effect, as well as the possible in
vivo protective effects of this molecular association.
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m/z = 850.16 [M + 3H+]3+ present in F11 and (B) the triply charged
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Additional file 3: Figure showing direct immunofluorescence (DIF)
of BHK-21 cell monolayer after treatment with RABV and: (A) 4
mg.mL−1 synthetic ocellatin-F1 tetrapeptide (OF1TP); (B) 4 mg.mL−1
synthetic rabies virus glycoprotein G tetrapeptide (RVGTP); (C)
negative control (MEM-FBS only) and (D) positive control (PV only).
Magnification 200 × . (PDF 35 kb)
Additional file 4: Evaluation of cytotoxicity of different molecules in
BHK-21 cell line after treatment with: (A) F11 (1 mg.mL−1); (B) OF1 (1
mg.mL−1); (C) OF1TP (6 mg.mL−1); (D) RGVTP (6 mg.mL−1) and (E)
bufotenine (0.8 mg.mL−1). (F) Negative control (MEM-FBS only) and (G)
positive control [DMSO (1:5) only]. Magnification 100 × . (PDF 89 kb)
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Fig. 4 Effect of different molecules tested individually or in association
as interfering agents of PV strain infection in BHK-21 cell line. Percentage
of inhibition. The effect of active fraction and bufotenine tested
individually compared to their effect in association (in red), the
effect of synthetic ocellatin-F1 and bufotenine tested individually
compared to their effect in association (blue), and the effect of
synthetic ocellatin-F1 tetrapeptide and bufotenine tested individually
compared to their effect in association (in black). F11: active fraction of
L. labyrinthicus skin secretion; OF1: synthetic ocellatin-F1; OF1TP:
synthetic ocellatin-F1 tetrapeptide; Bufo: bufotenine. ***(p < 0.001)
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